Open-House Biologika Discount Contracts 2025-24-Ranibizumab

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 119131530

  Document Type - Tender Notices

Description - Description: The companies involved pursue the goal of concluding discount contracts according to § 130a (8) SGB V with all suitable pharmaceutical entrepreneurs to the active ingredient ranibizumab. The conclusion of the contract takes place as par t of the open house biological procedure of the funds involved: Individual negotiations on contract content are not conducted, uniform conditions apply. The health insurance companies involved do not allow individual contractual partners to exclusiveness. The contract term is a maximum of 12 months starting on November 1st, 2025. The contract ends at the latest on October 31, 2026, regardless of the date of the contract. Entry to this open house

Gt Ref Id - 119131530

Deadline - Oct 31, 2026